»ó´Ü¿©¹é
HOME KSCMS
ÀúÇ×¼º°íÇ÷¾Ð ȯÀÚÀÇ Ç×°íÇ÷¾ÐÁ¦ Ä¡·á
- ¼º±Õ°üÀÇ´ë ¼º±âö ±³¼ö

ÀϹÝÀûÀ¸·Î ÀÌ´¢Á¦¸¦ Æ÷ÇÔÇØ ÀÛ¿ë±âÀüÀÌ ´Ù¸¥ Ç×°íÇ÷¾ÐÁ¦¸¦ 3°¡Áö À̻󠺴¿ëÅõ¿©ÇÏ°í °¢°¢ÀÇ ¾àÀÇ ¿ë·®À» ÃÖÀû ¿ë·®À¸·Î Åõ¿©Çصµ Ç÷¾ÐÀÌ 140/90mmHg ¹Ì¸¸À¸·Î Á¶ÀýµÇÁö ¾Ê´Â °æ¿ì¸¦ ‘ÀúÇ×¼º°íÇ÷¾Ð’À̶ó ÇÑ´Ù. ÀúÇ×¼º °íÇ÷¾ÐÀÇ À¯º´·üÀº º¸Åë 5~30%·Î º¸°íµÇ´Âµ¥, °¡¼º ÀúÇ×¼º°íÇ÷¾ÐÀ» ¹èÁ¦Çϸ頽ÇÁ¦·Î´Â 10% ¹Ì¸¸ÀÏ °ÍÀ¸·Î ÃßÃøµÈ´Ù. ÀúÇ×¼º °íÇ÷¾Ð È¯ÀÚ¿¡¼­ °íÇ÷¾ÐÀ¸·Î ÀÎÇÑ  ÇÕº´ÁõÀÇ ¹ß»ý À§ÇèÀº ±Þ°ÝÈ÷ Áõ°¡ÇϹǷΠÁø´Ü°ú Ä¡·á¿¡ ÁÖÀǸ¦ ¿äÇÑ´Ù.

ÀúÇ×¼º°íÇ÷¾ÐÀ» Ä¡·áÇϱâÀü ¹Ýµå½Ã °¡¼ºÀúÇ×¼º°íÇ÷¾Ð À¯¹«¸¦ È®ÀÎÇÏ°í ¿øÀο¡ µû¸¥ ´ëó°¡ ÇÊ¿äÇÏ´Ù. ÀúÇ×¼º°íÇ÷¾ÐÀ¸·Î ¿ÀÀεǴ ´ëÇ¥ÀûÀΠ°æ¿ì´Â Ç×°íÇ÷¾ÐÁ¦ º¹¿ëÀ» Áö½Ã´ë·Î µû¸£Áö ¾Ê´Â È¯ÀÚÀÇ ¼øÀÀµµ ºÎÁ·ÀÌ´Ù. ±âŸ °¨±â¾à, ºñ½ºÅ×·ÎÀ̵å¼Ò¿°ÁøÅëÁ¦, ºÎ½Å ÇÇÁú ½ºÅ×·ÎÀ̵å, ÇÇÀÓÁ¦, °úµµÇÑ ¼Ò±Ý ¼·Ãë, ºñ¸¸, °úµµÇÑ À½ÁÖ µîÀÌ ¿øÀÎÀÌ µÉ ¼ö ÀÖ´Ù.

°íÇ÷¾Ð¾à¿¡ ÀÌ´¢Á¦°¡ Æ÷ÇÔµÇÁö ¾Ê¾ÒÀ» ¶§´Â ¿ëÀû°úºÎÇϷΠÀúÇ×¼º°íÇ÷¾ÐÀÌ µÉ ¼ö ÀÖ´Ù. ¶ÇÇÑ ÀÌÂ÷¼º °íÇ÷¾ÐÀÌ ÀúÇ×¼º °íÇ÷¾ÐÀÇ ¿øÀÎÀÏ ¼öµµ ÀÖÀ¸¹Ç·Î ÀÌÂ÷¼º °íÇ÷¾Ð¿¡ ´ëÇÑ °¨º°ÀÌ ÇÊ¿äÇÒ ¼ö ÀÖ´Ù. ÀúÇ×¼º °íÇ÷¾ÐÀÇ Áø´Ü ½Ã ¸ÕÀú º¹¾à ¼øÀÀµµ¸¦ È®ÀÎÇÏ°í, °¡Á¤Ç÷¾ÐÀ̳ª È°µ¿Ç÷¾ÐÀ» ÃøÁ¤ÇØ ¹éÀÇ °íÇ÷¾ÐÀ» ¹èÁ¦ÇÑ ÈÄ ÀúÇ×¼º°íÇ÷¾Ð¿¡ ´ëÇÑ ¿øÀÎÀ» ±Ô¸íÇؾߠÇÑ´Ù.

»ç½Ç ÀúÇ×¼º°íÇ÷¾ÐÀ» Á¶ÀýÇϱâ À§ÇÑ ÃÖÀûÀÇ ¾à¹°Ä¡·á´Â Á¦´ë·Î ¿¬±¸µÇÁö ¾Ê¾Ò´Ù. È¿°úÀûÀΠġ·áÀû Á¢±ÙÀº »ýÈ°½À°ü º¯È­(ƯÈ÷ ³ªÆ®·ý ¼·ÃëÀÇ °¨¼Ò), Ç÷¾ÐÀÇ »ó½ÂÀ» À¯¹ßÇϴ ¹°ÁúÀÇ Áß´Ü, ±×¸®°í Á¶±â 3Á¦ º´¿ë¿ä¹ý¿¡ Àû±ØÀûÀΠÇ×°íÇ÷¾ÐÁ¦ Ãß°¡¸¦ ±âº»À¸·Î ÇÑ´Ù. ±Ã±ØÀûÀ¸·Î ¾Ë¾à ºÎ´ãÀ» ÁÙÀÌ°í Ä¡·á¿¡ ´ëÇÑ ¼øÀÀµµ¸¦ °³¼±Çϱâ À§ÇØ ´ÜÀϺ¹ÇÕÁ¦ »ç¿ëÀ» ÅëÇÑ ¾à¹° °³¼ö¸¦ °¨¼Ò½ÃÅ°´Â °ÍÀÌ ±ÇÀåµÈ´Ù.

°¡Àå È¿°úÀûÀΠÀü·«Àº Æ¯È÷ ½Å±â´É ÀúÇϠȯÀÚ¿¡¼­ ¼Ò±Ý ¼·ÃëÀÇ Á¦ÇÑ°ú ÇÔ²² ¿ëÀû °úºÎÇϸ¦ ÁÙÀ̱â À§ÇØ Ãß°¡ÀûÀ¸·Î ÀÌ´¢Á¦¸¦ Åõ¿©Çϴ °ÍÀÌ´Ù. ÀÌ °æ¿ì ±âÁ¸ ÀÌ´¢Á¦ Åõ¿©·®À» ´Ã¸®´Â °Íº¸´Ù ´Ù¸¥ Á¾·ùÀÇ °­·ÂÇÑ ÀÌ´¢Á¦·Î ´ëüÇϰųª Ãß°¡Çϴ °ÍÀÌ ±ÇÀ¯µÈ´Ù. »ç±¸Ã¼¿©°úÀ²ÀÌ 30mL/min/1.73m2 ¹Ì¸¸ÀΠ°æ¿ì Æ¼¾ÆÁöµå/Ƽ¾ÆÁöµå À¯»ç ÀÌ´¢Á¦¸¦ ·çÇÁ ÀÌ´¢Á¦·Î ´ëüÇؾߠÇÑ´Ù.

ÃÖ±ÙÀÇ ¿¬±¸¸¦ Á¾ÇÕÇØ º¸¸é ½ºÇǷγî¶ôÅæ(ÇÏ·ç ¿ë·® ÃÖ´ë 50mg/ÀÏ)À» ³× ¹ø° ¾à¹°·Î Ãß°¡ÇØ ¾Ëµµ½ºÅ×·ÐÀÇ »ý¹°ÇÐÀû È¿°ú¸¦ Â÷´ÜÇϴ °ÍÀÌ ÀúÇ×¼º°íÇ÷¾Ð Á¶ÀýÀ» À§ÇØ ÃßõÇؾߠÇѴٴ ±Ù°Å°¡ ´Ã¾î³ª°í ÀÖ´Ù. ÇÏÁö¸¸ ½ºÇǷγî¶ôÅæÀÇ Ç׾ȵå·Î°Õ ºÎÀÛ¿ëÀ¸·Î ÀÎÇØ Á¥°¡½¿ÀÇ ÅëÁõ, ½ÅÀå±â´ÉÀúÇÏ(6% À̳»), ³²¼ºÀÇ ¹ß±âºÎÀü, ¿©¼ºÀÇ »ý¸®ºÒ¼ø µîÀÌ »ý±æ ¼ö ÀÖÀ¸¹Ç·Î ¾à¹° »ç¿ë ÀüÈÄ ¸é¹ÐÇÑ °üÂûÀÌ ÇÊ¿äÇÏ´Ù.

ƯÈ÷, ½ºÇǷγî¶ôÅæÀÇ È¿´É°ú ¾ÈÀü¼ºÀº ½ÅÀåÀÌ Å©°Ô ¼Õ»óµÈ È¯Àڵ鿡°Ô¼­ È®¸³µÇÁö ¾Ê¾ÒÀ½À» ¸í½ÉÇؾߠÇÑ´Ù. µû¶ó¼­ ÀúÇ×¼º°íÇ÷¾Ð Ä¡·á¸¦  À§ÇÑ ½ºÇǷγî¶ôÅæÀÇ »ç¿ëÀº ÀϹÝÀûÀ¸·Î »ç±¸Ã¼¿©°úÀ²ÀÌ 45mL/min/1.73m2 ÀÌ»ó ¹× Ç÷Àå Ä®·ý ³óµµ°¡ 4.5mmol/L ÀÌÇÏÀΠȯÀڷΠÁ¦ÇÑÇÑ´Ù. ÀüÇØÁú¼öÄ¡¿Í »ç±¸Ã¼¿©°úÀ²À» ½ºÇǷγî¶ôÅæ Åõ¿© °³½Ã Á÷ÈÄ, ±×¸®°í ±× ÈÄ ÃÖ¼Ò Àϳ⿡ ÇÑ ¹øÀº ¸ð´ÏÅ͸µÇؾߠÇÑ´Ù. ½ºÇǷγî¶ôÅæ¿¡ ºÎÀÛ¿ëÀÌ Àִ °æ¿ì¿¡´Â ¿¡Ç÷¹·¹³í(50~100mg/day)À̳ª ¾Æ¹Ð·Î¶óÀ̵å(10~20mg/day)·Î ´ëüÇϴ °ÍÀÌ °¡´ÉÇÏ´Ù.

½ºÇǷγî¶ôÅæ¿¡ ´ëÇÑ ´ë¾ÈÀ¸·Î ºñ¼ÒÇÁ·Ñ·Ñ(5~10mg/day) ¶Ç´Â µ¶»çÁ¶½Å(4~8mg/day)À» »ç¿ëÇϸ頵Ѡ´Ù ½ºÇǷγî¶ôÅ游ŭ È¿°úÀûÀÌÁö´Â ¾Ê¾ÒÁö¸¸, ÀúÇ×¼º°íÇ÷¾ÐÀÇ ±âº» ¾à¹° Ä¡·á¿¡ Ãß°¡ÇßÀ» ¶§ À§¾à ´ëºñ Ç÷¾Ð °¨¼Ò È¿°ú°¡ ÇöÀúÇßÀ¸¹Ç·Î À̵頾๰ÀÇ Åõ¿©µµ °í·ÁÇغ¼¸¸ÇÏ´Ù.

½ºÇǷγî¶ôÅæÀÇ Ãß°¡·Îµµ Ç÷¾ÐÀÌ Á¶ÀýµÇÁö ¾Ê°Å³ª ºÎÀÛ¿ë µîÀ¸·Î ½ºÇǷγî¶ôÅæ »ç¿ëÀÌ ¾î·Á¿î ÇÏÀ̵å¶ö¶óÁøÀ̳ª ¹Ì³ì½Ãµô°ú °°Àº Á÷Á¢ÀûÀΠÇ÷°üÈ®ÀåÁ¦¸¦ Ãß°¡ÇÒ ¼ö ÀÖÀ¸³ª ÀÌ·± Ç÷°üÈ®ÀåÁ¦µéÀÌ  ½É°¢ÇѠü¾×Àú·ù¿Í ºó¸ÆÀ» À¯¹ßÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÚÁÖ »ç¿ëµÇÁö ¾Ê´Â´Ù.

»õ·Î¿î Ç÷¾Ð°­ÇÏÁ¦(nitric oxide donors, vasopressin antagonists, aldosterone synthase inhibitors, neutral endopeptidase inhibitors, and endothelin antagonists)ÀÇ È¿°ú´Â ¾ÆÁ÷ ¿¬±¸ ÁßÀ̳ª ±â´ëÇØ º¼¸¸ÇÏ´Ù.

References

1. 2018³â ´ëÇÑ°íÇ÷¾ÐÇÐȸ °íÇ÷¾Ð Áø·áÁöħ

2. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood     Pressure in Adults

3. 2018 ESC/ESH Guidelines for the management of arterial hypertension

THE MOST  webmaster@mostonline.co.kr

<ÀúÀÛ±ÇÀÚ © THE MOST, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>

#°íÇ÷¾Ð#Ç×°íÇ÷¾ÐÁ¦#ÀúÇ×¼º°íÇ÷¾Ð#½ºÇǷγî¶ôÅæ#

THE MOSTÀÇ ´Ù¸¥±â»ç º¸±â
iconÀαâ±â»ç
±â»ç ´ñ±Û 0°³
Àüüº¸±â
ù¹ø° ´ñ±ÛÀ» ³²°ÜÁÖ¼¼¿ä.
Back to Top